ADVANCED ENZYME TECHNOLOGIES
Back to Income Statement
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹746 Cr | ₹637 Cr | ₹624 Cr | ₹541 Cr | ₹529 Cr |
What is the latest Revenue of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹746 Cr |
| Mar2025 | ₹637 Cr |
| Mar2024 | ₹624 Cr |
| Mar2023 | ₹541 Cr |
| Mar2022 | ₹529 Cr |
How is Revenue of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹746 Cr | 17.09 | |
| Mar2025 | ₹637 Cr | 2.09 | |
| Mar2024 | ₹624 Cr | 15.39 | |
| Mar2023 | ₹541 Cr | 2.13 | |
| Mar2022 | ₹529 Cr | - | |
Compare Revenue of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,287.2 Cr | -0.2% | -11.2% | -12.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -0.2% |
-11.2% |
-12.7% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses